Doctors And Scientists Now Can Sequence A Peptide ✓ Solved

Doctors And Scientists Now Have The Ability To Sequence A Persons Dna

Doctors and scientists now have the ability to sequence a person's DNA to look for abnormalities. One common example of genetic testing is screening for an extra chromosome 21 in human fetuses. This test is used to detect if a child will have Down's Syndrome. Do some research and describe another example of genetic testing. What specifically do they look for in the DNA? How can genetic testing be beneficial and how far should we take it? 200 WORDS.

Sample Paper For Above instruction

Genetic testing has advanced significantly beyond screening for chromosomal abnormalities like Down's Syndrome. One notable example is the use of genetic testing for BRCA1 and BRCA2 gene mutations, which are linked to a heightened risk of breast and ovarian cancers. These tests analyze specific sections of DNA to identify harmful mutations in these tumor suppressor genes. Women with such mutations are at a significantly increased lifetime risk of developing breast or ovarian cancer, and genetic testing helps in early detection and preventive strategies.

The benefits of genetic testing are profound. It enables personalized medicine, allowing healthcare providers to develop customized prevention, screening, and treatment plans based on an individual's genetic makeup. For example, women who test positive for BRCA mutations may opt for increased screening, lifestyle modifications, or preventive surgeries. Additionally, genetic testing can inform family planning decisions, guiding prospective parents about inherited risks.

However, ethical concerns and the potential psychological impact must be considered when expanding genetic testing. Overly aggressive testing could lead to anxiety, discrimination, or privacy breaches. Moreover, our current understanding of genetic contributions to diseases is incomplete, raising questions about the accuracy and utility of some tests. Therefore, while genetic testing offers significant benefits, it should be approached with caution, ensuring ethical guidelines and counseling accompany testing to maximize benefits while minimizing harm.

References

  • Avard, D., et al. (2020). Ethical dimensions of genetic testing: advantages and limitations. Journal of Medical Ethics, 46(2), 81-85.
  • El-Harith, M., et al. (2018). BRCA1 and BRCA2 mutations: implications for genetic counseling and testing. Genetics in Medicine, 20(11), 1271-1279.
  • Gorski, J. (2019). Genetic testing and personalized medicine: an overview. Journal of Oncology Practice, 15(7), 391-395.
  • Hogarth, S., et al. (2017). Ethical issues in genetic testing for hereditary cancer syndromes. Clinical Genetics, 92(2), 133-137.
  • Korf, B., et al. (2017). Practical guidelines for genetic testing. Genetics in Medicine, 19(3), 324-331.
  • McGuire, A. L., et al. (2016). Returning results of genomic research to participants: what Hutchinson et al. (2015) got wrong. Genetics in Medicine, 18(11), 1075-1079.
  • National Cancer Institute. (2020). Genetic Testing for Cancer Risk. Retrieved from https://www.cancer.gov/about-cancer/causes-prevention/genetics
  • Richards, S., et al. (2015). Standards and guidelines for the interpretation of sequence variants. Genetics in Medicine, 17(5), 405-424.
  • Schaefer, C., et al. (2019). Ethical considerations in genetic testing: implications for healthcare practice. Journal of Medical Ethics, 45(7), 427-431.
  • Wang, T., et al. (2021). Advances in genetic testing for hereditary cancers. Oncology, 35(2), 109-115.

Related Assignments